Ikuti
Nigel Temperton
Nigel Temperton
Professor of Molecular Virology
Email yang diverifikasi di kent.ac.uk - Beranda
Judul
Dikutip oleh
Dikutip oleh
Tahun
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
J Seow, C Graham, B Merrick, S Acors, S Pickering, KJA Steel, ...
Nature microbiology 5 (12), 1598-1607, 2020
16392020
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins
D Corti, J Voss, SJ Gamblin, G Codoni, A Macagno, D Jarrossay, ...
Science 333 (6044), 850, 2011
13862011
SARS-CoV-2 evolution during treatment of chronic infection
SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ...
Nature 592 (7853), 277-282, 2021
10472021
Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ...
Cell 184 (16), 4220-4236. e13, 2021
8032021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ...
Nature 593 (7857), 136-141, 2021
7532021
Further antibody escape by Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, J Huo, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ...
bioRxiv, 2022
709*2022
T cell responses to whole SARS coronavirus in humans
CK Li, H Wu, H Yan, S Ma, L Wang, M Zhang, X Tang, NJ Temperton, ...
The Journal of Immunology 181 (8), 5490, 2008
5802008
Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine
D Corti, AL Suguitan Jr, D Pinna, C Silacci, BM Fernandez-Rodriguez, ...
The Journal of clinical investigation 120 (5), 1663, 2010
5252010
The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ...
Cell, 2021
3942021
Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure
CJ Reynolds, C Pade, JM Gibbons, AD Otter, KM Lin, D Muñoz Sandoval, ...
Science 377 (6603), eabq1841, 2022
3372022
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
E Andreano, E Nicastri, I Paciello, P Pileri, N Manganaro, G Piccini, ...
Cell 184 (7), 1821-1835. e16, 2021
2412021
Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules
A Hultberg, NJ Temperton, V Rosseels, M Koenders, M Gonzalez-Pajuelo, ...
PloS one 6 (4), e17665, 2011
2212011
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection
VVA Mallajosyula, M Citron, F Ferrara, X Lu, C Callahan, GJ Heidecker, ...
Proceedings of the National Academy of Sciences 111 (25), E2514-E2523, 2014
2162014
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
CJ Reynolds, L Swadling, JM Gibbons, C Pade, MP Jensen, MO Diniz, ...
Science immunology 5 (54), eabf3698, 2020
2112020
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes
NJ Temperton, PK Chan, G Simmons, MC Zambon, RS Tedder, ...
Emerg Infect Dis 11 (3), 411-416, 2005
2112005
Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi
SR Wilkinson, NJ Temperton, A Mondragon, JM Kelly
Journal of Biological Chemistry 275 (11), 8220-8225, 2000
2112000
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
NK Alharbi, E Padron-Regalado, CP Thompson, A Kupke, D Wells, ...
Vaccine 35 (30), 3780-3788, 2017
1912017
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
SA Kemp, DA Collier, R Datir, IATM Ferreira, S Gayed, A Jahun, ...
medRxiv doi.org/10.1101/2020.12.05.20241927, 2020
1832020
A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
NJ Temperton, K Hoschler, D Major, C Nicolson, R Manvell, VM Hien, ...
Influenza and other respiratory viruses 1 (3), 105-112, 2007
1752007
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ...
Cell 185 (12), 2116-2131. e18, 2022
1572022
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20